|
NOVO-B
|
Novo Nordisk A/S
|
3.97%
|
DK
|
CO
|
|
LLY
|
Eli Lilly and Company
|
3.95%
|
US
|
NYSE
|
|
AMGN
|
Amgen Inc.
|
3.67%
|
US
|
NASDAQ
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
3.47%
|
US
|
NASDAQ
|
|
BSX
|
Boston Scientific Corporation
|
3.46%
|
US
|
NYSE
|
|
AZN
|
Astrazeneca PLC
|
3.42%
|
US
|
NASDAQ
|
|
JNJ
|
Johnson & Johnson
|
3.30%
|
US
|
NYSE
|
|
ABBV
|
AbbVie Inc.
|
3.29%
|
US
|
NYSE
|
|
BMY
|
Bristol-Myers Squibb Company
|
3.23%
|
US
|
NYSE
|
|
SYK
|
Stryker Corporation
|
3.18%
|
US
|
NYSE
|
|
DXCM
|
DexCom, Inc.
|
3.03%
|
US
|
NASDAQ
|
|
ALC
|
Alcon AG
|
3.00%
|
CH
|
SW
|
|
BIIB
|
Biogen Idec Inc.
|
2.93%
|
US
|
NASDAQ
|
|
RO
|
Roche Holding AG
|
2.77%
|
CH
|
SW
|
|
MDT
|
Medtronic Inc.
|
2.41%
|
US
|
NYSE
|
|
WELL
|
Welltower Inc.
|
2.40%
|
US
|
NYSE
|
|
EW
|
Edwards Lifesciences Corporation
|
2.13%
|
US
|
NYSE
|
|
ZBH
|
Zimmer Biomet Holdings, Inc.
|
1.88%
|
US
|
NYSE
|
|
BGNE
|
BeiGene, Ltd.
|
1.79%
|
US
|
NASDAQ
|
|
SGEN
|
Seattle Genetics, Inc.
|
1.77%
|
US
|
NASDAQ
|